DRKS00023626已完成不适用
Erythroblasts as a parameter for mortality in critical ill patients supported with extacorporeal membrane oxygenation. A retrospective study - ECBLAS
Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH0 个研究点目标入组 30 人开始时间: 2020年12月10日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •All critical ill patients supported with ECMO for more than 48 hours were permitted.
排除标准
- •Critical ill patients supported with ECMO for less than 48 hours were excluded.
研究者
相似试验
招募中
不适用
Study of mature and immature red blood cell indices in iron deficiency statusCTRI/2015/05/005776Dr Salman Akther150
进行中（未招募）
不适用
A retrospective study for mortality prediction of neutrophil to lymphocyte and platelet ratio in severe trauma patientsInjury, poisoning and certain other consequences of external causesKCT0004131Ajou University Hospital300
招募中
不适用
Prediction of hematotoxicity and non-hematological toxicity of systemic therapies and other clinical outcome parameters for patients with locally advanced gastric cancer or gastroesophageal transition (AEG I-III by Siewert) and patients with pancreatic carcinomaC15C16C25Malignant neoplasm of oesophagusMalignant neoplasm of stomachMalignant neoplasm of pancreasDRKS00021415niversitäres Krebszentrum Leipzig (UCCL)35
未知
不适用
Comparing blood cell damage in two types of heart-lung machines in patients undergoing open-heart surgeryPatients undergoing coronary artery bypass grafting with cardiopulmonary bypassSurgeryISRCTN11514932Amphia Ziekenhuis40
招募中
不适用
To evaluate the availability of intra-erythrocytic oxaliplatin and plasma oxaliplatin for patients who received oxaliplatin containing adjuvant chemotherapyColon cancerJPRN-UMIN000009128Tokushima University Hospital20